Yali Dou Selected Research

Yali Dou Research Topics

Disease

21	Neoplasms (Cancer) 11/2023 - 01/2005
18	Leukemia 01/2021 - 01/2005
3	Neoplasm Metastasis (Metastasis) 08/2023 - 01/2022
3	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2013
2	Neurodevelopmental Disorders 09/2023 - 01/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2023 - 01/2022
2	Ovarian Neoplasms (Ovarian Cancer) 05/2016 - 11/2015
2	Colonic Neoplasms (Colon Cancer) 01/2016 - 05/2014
2	Carcinogenesis 06/2015 - 05/2013
2	Sepsis (Septicemia) 04/2010 - 02/2008
1	Carcinoma (Carcinomatosis) 11/2022
1	Adenocarcinoma 01/2022
1	Pneumonia (Pneumonitis) 01/2021
1	COVID-19 01/2021
1	Cytokine Release Syndrome 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Fatty Liver 01/2021
1	Genetic Translocation (Chromosomal Translocation) 03/2020
1	Heart Failure 01/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Fatigue 01/2019
1	Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita) 01/2018
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2018
1	Triple Negative Breast Neoplasms 01/2017
1	Primitive Neuroectodermal Tumors (PNET) 11/2016
1	Retinoblastoma (Glioblastoma, Retinal) 11/2015
1	Colorectal Neoplasms (Colorectal Cancer) 05/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2013
1	Lymphoma (Lymphomas) 05/2013
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2013
1	Peritonitis 02/2008

Drug/Important Bio-Agent (IBA)

14	MethyltransferasesIBA 09/2023 - 10/2005
13	Histones (Histone)IBA 06/2020 - 10/2005
10	Proteins (Proteins, Gene)FDA Link 06/2020 - 01/2005
8	Histone MethyltransferasesIBA 11/2023 - 01/2005
7	Lysine (L-Lysine)FDA Link 06/2020 - 07/2010
5	EnzymesIBA 09/2023 - 11/2016
3	PeptidomimeticsIBA 01/2019 - 01/2017
2	ChromatinIBA 11/2023 - 01/2020
2	activin AIBA 08/2023 - 01/2022
2	Activins (Activin)IBA 08/2023 - 01/2022
2	Histone DemethylasesIBA 01/2022 - 01/2016
2	LipidsIBA 01/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2016
2	MM-401IBA 01/2017 - 01/2014
2	ChemokinesIBA 01/2016 - 11/2015
2	Transcription Factors (Transcription Factor)IBA 12/2011 - 10/2006
1	p38 Mitogen-Activated Protein KinasesIBA 08/2023
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 11/2022
1	MTOR InhibitorsIBA 01/2022
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2021
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Etanercept (Enbrel)FDA Link 01/2021
1	Baclofen FDA LinkGeneric 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Apolipoproteins B (ApoB)IBA 01/2020
1	phospholambanIBA 01/2020
1	NucleophosminIBA 01/2020
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Oncogene Proteins (Oncogene Protein)IBA 01/2018
1	telomerase RNA (bTR)IBA 01/2018
1	compound 18IBA 01/2017
1	Intrinsically Disordered ProteinsIBA 01/2017
1	Hematoxylin (Haematoxylon)IBA 11/2016
1	Formaldehyde (Formol)FDA Link 11/2016
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2016
1	ParaffinIBA 11/2016
1	PlatinumIBA 05/2016
1	Polycomb Repressive Complex 2IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 11/2015
1	Retinaldehyde (Retinal)IBA 11/2015
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2014
1	LigandsIBA 05/2014
1	Chemokine ReceptorsIBA 05/2014
1	Interleukin-22 (IL-22)IBA 05/2014
1	Messenger RNA (mRNA)IBA 05/2013
1	Immunoglobulins (Immunoglobulin)IBA 05/2013
1	Peptides (Polypeptides)IBA 07/2010
1	salicylhydroxamic acid (SHAM)IBA 06/2010
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 10/2006
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2005

Therapy/Procedure

7	Therapeutics 01/2022 - 06/2015
4	Immunotherapy 01/2020 - 11/2015
2	Punctures 04/2010 - 02/2008
2	Ligation 04/2010 - 02/2008
1	Drug Therapy (Chemotherapy) 05/2016
1	Molecular Targeted Therapy 11/2015